课题基金 / 基金详情

Respiratory Evaluation Sciences Program (RESP): Innovations in analytic approaches to improve efficiency in respiratory care

Respiratory Evaluation Sciences Program (RESP): Innovations in analytic approaches to improve efficiency in respiratory care
呼吸评估科学计划 (RESP):提高呼吸护理效率的分析方法创新
批准号:
340763
负责人:
Sadatsafavi Mohsen
金额:
$21.86万
依托单位国家:
加拿大
项目类别:
Salary Programs
财政年份:
2015
资助国家:
加拿大
项目状态:
已结题
起止时间:
2015-12-01 至 2020-12-01

项目摘要

项目成果

Sadatsafavi Mohsen的其他基金

相似基金

相关文献

中文摘要
翻译
慢性呼吸道疾病,特别是哮喘和慢性阻塞性肺疾病(COPD),是导致死亡和残疾的主要原因之一,并导致我们的医疗保健成本上升。哮喘是患者缺课的主要原因
英文摘要
Chronic respiratory diseases, in particular asthma and chronic obstructive pulmonary disease (COPD), are among the leading causes of death and disability, and contribute to our raising health care costs. Asthma is a major cause of patients missing school
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IMplementing Predictive Analytics towards efficient COPD Treatments (IMPACT)
  • 批准号:
    441752
  • 项目类别:
    Operating Grants
  • 资助金额:
    $144.71万
  • 财政年份:
    2020
  • 负责人:
    Sadatsafavi Mohsen
  • 依托单位:
Development, validation, and dissemination of an individualized prediction tool for acute exacerbations of chronic obstructive pulmonary disease
  • 批准号:
    365323
  • 项目类别:
    Operating Grants
  • 资助金额:
    $14.45万
  • 财政年份:
    2017
  • 负责人:
    Sadatsafavi Mohsen
  • 依托单位:
Interventions for undiagnosed and early-stage COPD: Informing policy, practice, and research through an Evaluation Platform in COPD (EPIC)
  • 批准号:
    323789
  • 项目类别:
    Operating Grants
  • 资助金额:
    $12.83万
  • 财政年份:
    2015
  • 负责人:
    Sadatsafavi Mohsen
  • 依托单位:
EmPhAsIS: Empowering Pharmacists in Asthma management through Interactive SMS
海外基金